LRRK2 kinase inhibition reverses G2019S mutation-dependent effects on tau pathology progression

Noah Lubben, Julia K. Brynildsen, Connor M. Webb, Howard L. Li, Cheryl E. G. Leyns, Lakshmi Changolkar, Bin Zhang, Emily S. Meymand, Mia O’Reilly, Zach Madaj, Daniella DeWeerd, Matthew J. Fell, Virginia M. Y. Lee, Dani S. Bassett, Michael X. Henderson

Translational Neurodegeneration ›› 2024, Vol. 13 ›› Issue (0) : 13.

PDF(15810 KB)
PDF(15810 KB)
Translational Neurodegeneration ›› 2024, Vol. 13 ›› Issue (0) : 13. DOI: 10.1186/s40035-024-00403-2
RESEARCH

LRRK2 kinase inhibition reverses G2019S mutation-dependent effects on tau pathology progression

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2024, 13(0): 13 https://doi.org/10.1186/s40035-024-00403-2

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(15810 KB)

Accesses

Citation

Detail
Sections
Recommended
  • Address: No.181-7 Ruijin er Road, Huangpu District, Shanghai, China
    Zip code: 200020
  • Tel: +86-21-64370045-662960
  • E-mail: trans_neuro@126.com

扫码关注了解更多
Copyright © Shanghai Jiao Tong University, 沪交ICP备20180049
Powered by Beijing Magtech Co. Ltd

/

〈 〉